KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Amortizatization of Intangibles (2018 - 2025)

Historic Amortizatization of Intangibles for Xenon Pharmaceuticals (XENE) over the last 6 years, with Q3 2025 value amounting to $330000.0.

  • Xenon Pharmaceuticals' Amortizatization of Intangibles rose 476.19% to $330000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 13507.16%. This contributed to the annual value of $1.3 million for FY2024, which is 338.0% up from last year.
  • According to the latest figures from Q3 2025, Xenon Pharmaceuticals' Amortizatization of Intangibles is $330000.0, which was up 476.19% from $327000.0 recorded in Q2 2025.
  • In the past 5 years, Xenon Pharmaceuticals' Amortizatization of Intangibles ranged from a high of $330000.0 in Q3 2025 and a low of -$4.6 million during Q4 2023
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $317000.0 (2024), whereas its average is -$300375.0.
  • In the last 5 years, Xenon Pharmaceuticals' Amortizatization of Intangibles surged by 10688.09% in 2024 and then soared by 420.71% in 2025.
  • Over the past 3 years, Xenon Pharmaceuticals' Amortizatization of Intangibles (Quarter) stood at -$4.6 million in 2023, then soared by 106.88% to $319000.0 in 2024, then increased by 3.45% to $330000.0 in 2025.
  • Its last three reported values are $330000.0 in Q3 2025, $327000.0 for Q2 2025, and $322000.0 during Q1 2025.